Survival outcomes associated with completion of adjuvant oxaliplatin‐based chemotherapy for stage III colon cancer: A national population‐based study

The impact of cycle completion rates of oxaliplatin‐based adjuvant chemotherapy for stage III colon cancer in real‐world practice is unknown. We assessed its impact, and that of treatment modification, on 3‐year cancer‐specific mortality. Four thousand one hundred and forty‐seven patients with patho...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of cancer 2022-01, Vol.150 (2), p.335-346
Hauptverfasser:	Boyle, Jemma M., Kuryba, Angela, Cowling, Thomas E., Meulen, Jan, Fearnhead, Nicola S., Walker, Kate, Braun, Michael S., Aggarwal, Ajay
Format:	Artikel
Sprache:	eng
Schlagworte:	adjuvant chemotherapy Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols - therapeutic use Cancer Capecitabine - administration & dosage Chemotherapy Chemotherapy, Adjuvant - mortality Colon cancer Colonic Neoplasms - drug therapy Colonic Neoplasms - mortality Colonic Neoplasms - pathology Colorectal cancer completion of treatment epidemiology Female Fluorouracil - administration & dosage Follow-Up Studies Humans Leucovorin - administration & dosage Male Medical prognosis Medical research Middle Aged Mortality Neoplasm Staging Oxaliplatin Oxaliplatin - administration & dosage Patients Population studies Population-based studies Prospective Studies stage III Survival Survival Rate Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!